These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 4195771)

  • 1. Leucocyte phenotypes in Hodgkin's disease.
    Zervas JD; Delamore IW; Israëls MC
    Lancet; 1970 Sep; 2(7674):634-5. PubMed ID: 4195771
    [No Abstract]   [Full Text] [Related]  

  • 2. Leucocyte antigens in Hodgkin's disease.
    Forbes JF; Morris PJ
    Lancet; 1970 Oct; 2(7678):849-51. PubMed ID: 4097757
    [No Abstract]   [Full Text] [Related]  

  • 3. Leucocyte phenotypes in Hodgkin's disease.
    Burch PR
    Lancet; 1970 Oct; 2(7676):771-2. PubMed ID: 4195991
    [No Abstract]   [Full Text] [Related]  

  • 4. Lymphocyte transformation and production of a human mononuclear leucocyte chemotactic factor in patients with Hodgkin's disease.
    Rühl H; Vogt W; Bochert G; Schmidt S; Schaoua H; Moelle R
    Clin Exp Immunol; 1974 Jul; 17(3):407-15. PubMed ID: 4468860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ferritin, a sensitizing substance in the leucocyte migration inhibition test in patients with malignant lymphoma.
    Hancock BW; Bruce L; May K; Richmond J
    Br J Haematol; 1979 Oct; 43(2):223-33. PubMed ID: 116671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro detection of cell-mediated immunity to antigens associated with Hodgkin's granulomas.
    Andersen E
    Scand J Haematol; 1977 Apr; 18(4):343-7. PubMed ID: 857295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hodgkin's disease from the standpoint of immunology].
    Kuroyanagi T; Hosokawa Z; Sukigara M
    Nihon Rinsho; 1974 Jun; 32(6):1213-20. PubMed ID: 4610217
    [No Abstract]   [Full Text] [Related]  

  • 8. Genetic factors in Hodgkin's disease: association with a disease-susceptibility locus (DSA) in the HL-A region.
    Bodmer WF
    Natl Cancer Inst Monogr; 1973 May; 36():127-34. PubMed ID: 4744574
    [No Abstract]   [Full Text] [Related]  

  • 9. Hodgkin's disease. An immunodepleting and immunosuppressive disorder.
    Twomey JJ; Laughter AH; Farrow S; Douglass CC
    J Clin Invest; 1975 Aug; 56(2):467-75. PubMed ID: 125290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pathogenesis of Hodgkin's disease.
    Stuart AE
    J Pathol; 1978 Dec; 126(4):239-54. PubMed ID: 372510
    [No Abstract]   [Full Text] [Related]  

  • 11. Quantitative ultrastructural analysis of in vivo lymphocyte-Reed-Sternberg cell interactions in Hodgkin's disease.
    Archibald RB; Frenster JH
    Natl Cancer Inst Monogr; 1973 May; 36():239-45. PubMed ID: 4542772
    [No Abstract]   [Full Text] [Related]  

  • 12. Delayed cutaneous hypersensitivity and blood lymphocyte count in advanced Hodgkin's and non-Hodgkin's lymphomas.
    Gupta S; Seth SK; Udupa KN; Sen PC; Rastogi BL
    Ann Chir Gynaecol; 1980; 69(2):79-83. PubMed ID: 7377739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lawrence transfer factor and Hodgkin's disease.
    Smith RA; Ezdinli E; Bigley NJ; Han T
    Lancet; 1973 Feb; 1(7800):434. PubMed ID: 4119754
    [No Abstract]   [Full Text] [Related]  

  • 14. Heterogeneity in Hodgkin's disease: no simple answer for a complex disorder.
    Anastasi J; Variakojis D
    Hum Pathol; 1988 Nov; 19(11):1251-4. PubMed ID: 3181947
    [No Abstract]   [Full Text] [Related]  

  • 15. [Bactericidal and phagocytic properties of leukocytes and the bactericidal activity of the plasma in patients with Hodgkin's disease in remission].
    Wysocka J; Kemona H; Prokopowicz J; Kiluk S
    Przegl Lek; 1987; 44(2):281-4. PubMed ID: 3615932
    [No Abstract]   [Full Text] [Related]  

  • 16. Proceedings: Immunological depletion contributing to familial Hodgkin's disease.
    Fenelly JJ; McBride A
    Br J Cancer; 1974 Aug; 30(2):182. PubMed ID: 4419391
    [No Abstract]   [Full Text] [Related]  

  • 17. Leucocyte migration inhibition and leucocyte adherence inhibition studies, using ferritin as 'antigen', in patients with malignant lymphoma.
    Bruce L; Grail A; Hancock BW
    Hematol Oncol; 1984; 2(2):169-77. PubMed ID: 6745868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. International symposium on Hodgkin's disease. Session 2. Histopathology and experimental cytology. Invited discussion: Synthesis and implications for the etiology, pathogenesis and spread of Hodgkin's disease.
    Berard CW
    Natl Cancer Inst Monogr; 1973 May; 36():261-3. PubMed ID: 4355349
    [No Abstract]   [Full Text] [Related]  

  • 19. Leucocyte zinc in non-Hodgkin's lymphoma and Hodgkin's disease.
    Field HP; Jones R; Walker BE; Kelleher J; Simmons AV
    Nutr Cancer; 1988; 11(2):83-92. PubMed ID: 3362723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hodgkin's disease: study of delayed hypersensitivity of 64 non treated patients. Value of epicutaneous test using croton oil].
    Goasguen J; Leblay R; Guerin D; Le Prise PY; Richier JL
    Sem Hop; 1977 Jan; 53(4):219-25. PubMed ID: 189435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.